SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Afaq Sarwar who wrote (9277)6/6/1998 11:13:00 PM
From: blankmind  Respond to of 23519
 
- Latest 10Q on Edgar shows about $45 million on hand - not $13 mill.

<S> <C> <C>
Current assets:
Cash...................................................... $ 3,897 $ 6,161
Available-for-sale securities............................. 9,038 52,955
Accounts receivable....................................... 16,922 11,791
Inventories............................................... 11,675 9,084
Prepaid expenses and other assets......................... 1,971 1,636
-------- --------
Total current assets.............................. 43,503 81,627
Property and equipment...................................... 41,901 36,462
Available-for-sale securities, non-current.................. 31,270 32,580
-------- --------
Total............................................. $116,674 $150,669
======== ========



To: Afaq Sarwar who wrote (9277)6/6/1998 11:38:00 PM
From: RCMac  Respond to of 23519
 
Afaq,
On the change in VIVUS's cash position, see the April 9 press release concerning first quarter results:

"Cash, cash equivalents and available-for-sale securities at March 31, 1998 totaled $44.2 million, compared with $91.7 million at December 31, 1997. The $47.5 million decline in cash resulted from several factors, including the Company's repurchase of its common stock ($23.6 million), capital spending associated with the new manufacturing facility, payment [$5 million] of the lawsuit settled in the fourth quarter of 1997 and payment of 1997 sales commissions."

"In addition, the Company shipped approximately $16.5 million of its first quarter product revenues in the month of March, resulting in accounts receivable of $16.9 million at March 31, 1998, approximately $5.1 million higher than December 31, 1997. Inventories increased $2.6 million almost entirely due to increased work-in-process. Property and equipment at March 31, 1997 increased by $5.4 million from December 31, 1997 primarily resulting from additional costs associated with the Company's new 90,000 square foot production facility in New Jersey and its new corporate headquarters. "

The full release is at go2net.newsalert.com

-- RCM